The DOI matches its Crossref record, with a small difference in title or year; 97 of the 100 references it cites were found in a registry or an index.
Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Open accessAbstract
Importance: Incorporating nontraditional risk factors may improve the performance of traditional multivariable risk assessment for cardiovascular disease (CVD). Objective: To systematically review evidence for the US Preventive Services Task Force on the benefits and harms of 3 nontraditional risk factors in cardiovascular risk assessment: the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, and coronary artery calcium (CAC) score. Data Sources: MEDLINE, PubMed, and the Cochrane Central Register of Controlled Trials for studies published through May 22, 2017. Surveillance continued through February 7, 2018. Study Selection: Studies of asymptomatic adults with no known cardiovascular disease. Data Extraction and Synthesis: Independent critical appraisal and data abstraction by 2 reviewers. Main Outcomes and Measures: Cardiovascular events, mortality, risk assessment performance measures (calibration, discrimination, or risk reclassification), and serious adverse events. Results: Forty-three studies (N = 267 244) were included. No adequately powered trials have evaluated the clinical effect of risk assessment with nontraditional risk factors on patient health outcomes. The addition of the ABI (10 studies), hsCRP level (25 studies), or CAC score (19 studies) can improve both discrimination and reclassification; the magnitude and consistency of improvement varies by nontraditional risk factor. For the ABI, improvements in performance were the greatest for women, in whom traditional risk assessment has poor discrimination (C statistic change of 0.112 and net reclassification index [NRI] of 0.096). Results were inconsistent for hsCRP level, with the largest analysis (n = 166 596) showing a minimal effect on risk prediction (C statistic change of 0.0039, NRI of 0.0152). The largest improvements in discrimination (C statistic change ranging from 0.018 to 0.144) and reclassification (NRI ranging from 0.084 to 0.35) were seen for CAC score, although CAC score may inappropriately reclassify individuals not having cardiovascular events into higher-risk categories, as determined by negative nonevent NRI. Evidence for the harms of nontraditional risk factor assessment was limited to computed tomography imaging for CAC scoring (8 studies) and showed that radiation exposure is low but may result in additional testing. Conclusions and Relevance: There are insufficient adequately powered clinical trials evaluating the incremental effect of the ABI, hsCRP level, or CAC score in risk assessment and initiation of preventive therapy. Furthermore, the clinical meaning of improvements in measures of calibration, discrimination, and reclassification risk prediction studies is uncertain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A recent meta-analysis from the US Preventive Services Task Force summarized the available evidence on the value of non-traditional risk factors for risk prediction, and found that, although there are no randomized trials showing that the use of CAC reduces health outcomes, nevertheless it improves both discrimination and reclassification [19].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2014) · Medical Entomology and Zoology · Cited by 17,633
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures
Steyerberg, E. W., Vickers, A. J., Cook, N. R., Gerds, T., Gonen, M., Obuchowski, N., Pencina, M. J., & Kattan, M. W. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181c30fb2 · Cited by 5,170
Flagged first, then by citations
3 of the 100 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- US Preventive Services Task Force, 2015, US Preventive Services Task Force Procedure Manual
Cited by
Sorted by citations
Items 201–215 of 215
Lortz, J., Rassaf, T., Jansen, C., Knuschke, R., Schweda, A., Schnaubert, L., Rammos, C., Köberlein-Neu, J., Skoda, E.-M., Teufel, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26617717
Gene-exposure interactions regulate cytokine-mediated chronic inflammation and cardiac remodelingPreprint
Corianò, M., Tahasildar, S., Huang, L., Rjoob, K. W. Y., Kalaie, S., Zheng, J., Curran, L., Gifani, P., Dumas, M., & O’Regan, D. P. (2026) · medRxiv · doi:10.64898/2026.01.19.26344405
Blinc, A., Boc, V., & Schaefer, C. A. (2026) · Springer eBooks · doi:10.1007/978-3-031-82232-2_25
Harangi, M., Nádró, B., Diószegi, Á., & Paragh, G. (2026) · Magyar Belorvosi Archívum · doi:10.59063/mba.2026.79.1.2
Inflammatory Markers for the General Cardiology Practitioner: A Primer
McFarlane, S. A., Murphy, N. P., & Feinstein, M. J. (2026) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2026.03.034
Wang, T., Sandhu, A., Vamvakas, K., Bergman, H., Grad, R. M., Vedel, I., Gagnon, M., Yousefi, S., & Abbasgholizadeh-Rahimi, S. (2026) · FACETS · doi:10.1139/facets-2025-0048
Rhee, T., Ahn, H., Lee, K., Choi, J., Lee, S., Oh, S., Lip, G. Y. H., & Choi, E. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.03.1964
A Robust Random Forest Framework for Early Heart Disease Prediction
Khan, M. A. M., Sayem, S., Abid, M. A. S., Chowdhury, M. K., Maniruzzaman, M., & Jaman, M. S. (2026) · IEEE International Conference on Communication Systems and Network Technologies (CSNT) · doi:10.1109/csnt69054.2026.11502579
Çelenk, Y. B., Yakar, B., Kaya, M. O., & Önalan, E. (2026) · Journal of Clinical Hypertension · doi:10.1111/jch.70313
Jin, B., Lin, C., Wu, M. C., Chen, B., Han, Y., Zhang, X., Bai, X., Yang, Y., Cui, J., Xu, W., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-110220
Biomarkers in Vascular Disease
Brieger, D. G., Schwarzkopf, P., Psaltis, P. J., & Figtree, G. A. (2026) · Springer eBooks · doi:10.1007/978-3-032-19328-5_15
Arnold, M. J., Spacek, L., Bush, K. N. V., Waring, A. A., Ballard‐Hernandez, J., Beckman, D., Kelley, C., Natarajan, S., Neubauer, B. E., Phillips, E. M., et al. (2026) · Annals of Internal Medicine · doi:10.7326/annals-26-01374
Anxiety disorders, PTSD, and risk of first-ever stroke: A meta-analysis of 11 million participants
Imtiaz, N., Ranjan, R., Ken‐Dror, G., Han, T. S., & Sharma, P. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122527
State-of-the-Art Imaging Biomarkers in Screening of Atherosclerotic Cardiovascular Disease
Sorin, V., Fatade, K., Morris, M. F., Gupta, A. B., & Rajiah, P. S. (2026) · Radiographics · doi:10.1148/rg.260068
The cardiovascular risk of metabolically healthy obesity: an inflammatory perspective
Lozano-Núñez, J., Lakshmi, A., Benny, B. A., Sharma, P., Jayakumar, A., & Swathi, N. L. (2026) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2026-0266
Metadata
- Authors
- Lin, J. S., Evans, C. V., Johnson, E., Redmond, N., Coppola, E. L., & Smith, N.
- Affiliations
- Kaiser Permanente (US)
- Corresponding author
- Lin, Jennifer S.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2018-07-17
- Volume
- 320
- Issue
- 3
- Pages
- 281
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC13564044
- OpenAlex
- W2852998865
- Cited by
- 216
- References
- 100
- Citations by year
- 2026: 19 · 2025: 28 · 2024: 24 · 2023: 30 · 2022: 27 · 2021: 38 · 2020: 30 · 2019: 14 · 2018: 6
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- JAMA (publishedVersion, public-domain)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, public-domain)
- Funders
- U.S. Department of Health and Human Services
- Agency for Healthcare Research and Quality (HHSA 290-2015-00007-I)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- cardiovascular disease risk assessment, non-traditional risk factors, ankle-brachial index, high-sensitivity C-reactive protein, coronary artery calcium score, risk reclassification, risk discrimination, cardiovascular events, cardiovascular mortality, radiation exposure, women, asymptomatic adults, USPSTF recommendations, cardiovascular risk prediction models, computed tomography, net reclassification improvement
- MeSH terms
- Adult, C-Reactive Protein, Cardiovascular Diseases, Clinical Trials as Topic, Coronary Artery Disease, Humans, Risk Factors, Biomarkers, Risk Assessment, Ankle Brachial Index, Vascular Calcification
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
